In recent trading session, Dexcom Inc (NASDAQ:DXCM) saw 1.05 million shares changing hands at last check today with its beta currently measuring 1.42. Company’s recent per share price level of $69.57 trading at $2.71 or 4.05% at last check today assigns it a market valuation of $27.28B. That most recent trading price of DXCM’s stock is at a discount of -100.14% from its 52-week high price of $139.24 and is indicating a premium of 17.32% from its 52-week low price of $57.52. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 4.93 million shares which gives us an average trading volume of 4.23 million if we extend that period to 3-months.
For Dexcom Inc (DXCM), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.48. Splitting up the data highlights that, out of 12 analysts covering the stock, 0 rated the stock as a Sell while 1 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 10 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0.33 in the current quarter.
Dexcom Inc (NASDAQ:DXCM) trade information
Upright in the green today for gaining 4.05%, in the last five days DXCM remained trading in the green while hitting it’s week-highest on Wednesday, 04/23/25 when the stock touched $69.57 price level, adding 0.91% to its value on the day. Dexcom Inc’s shares saw a change of -10.55% in year-to-date performance and have moved 1.21% in past 5-day. Dexcom Inc (NASDAQ:DXCM) showed a performance of -5.42% in past 30-days. Number of shares sold short was 11.01 million shares which calculate 2.43 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 95 to the stock, which implies a rise of 26.77% to its recent value today. Analysts have been projecting 28.125 as a low price target for the stock while placing it at a high target of 146. It follows that stock’s current price would jump 59.57% in reaching the projected high whereas dropping to the targeted low would mean a gain of 59.57% for stock’s current value.
Dexcom Inc (DXCM) estimates and forecasts
This year revenue growth is estimated to rise 14.20% from the last financial year’s standing.
20 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 1.02B for the same. And 20 analysts are in estimates of company making revenue of 1.13B in the next quarter. Company posted 921M and 1B of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 39.06% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 23.32% while estimates for its earnings growth in next 5 years are of 22.57%.
Dexcom Inc (NASDAQ:DXCM)’s Major holders
Insiders are in possession of 0.41% of company’s total shares while institution are holding 96.15 percent of that, with stock having share float percentage of 96.54%. Investors also watch the number of corporate investors in a company very closely, which is 96.15% institutions for Dexcom Inc that are currently holding shares of the company. VANGUARD GROUP INC is the top institutional holder at DXCM for having 46.51 million shares of worth $5.27 billion. And as of 2024-06-30, it was holding 11.6516 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 34.52 million shares on 2024-06-30. The number of shares represents firm’s hold over 8.6471 of outstanding shares, having a total worth of $3.91 billion.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard 500 Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 12.26 shares of worth $853.26 million or 3.13% of the total outstanding shares. The later fund manager was in possession of 10.57 shares on Dec 31, 2024 , making its stake of worth around $735.89 million in the company or a holder of 2.70% of company’s stock.
